Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zeria

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Zeria's Japan sales performance.

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir

The US and Japan have also approved emergency use of remdesivir, while the European Commission has issued recommendations for compassionate use and started a rolling review of its use in coronavirus

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients The US and Japan have also approved emergency use of remdesivir, while the European Commission has issued recommendations for compassionate use and started a rolling review of its use in coronavirus

Merck buys Themis as part of drive for COVID-19 drugs and vaccines

Merck buys Themis as part of drive for COVID-19 drugs and vaccines Japan and UK.

Gilead, Galapagos dip on mixed ulcerative colitis data

Gilead, Galapagos dip on mixed ulcerative colitis data Filgotinib is already under regulatory review in the US, Europe and Japan as a treatment for rheumatoid arthritis, but Gilead and Galapagos will need to extend the use of the drug

Biopharma body welcomes EU-UK free trade agreement docs

Biopharma body welcomes EU-UK free trade agreement docs The UK seeks an FTA close to those agreed by the EU with Canada or Japan. ... union, and instead is seeking a free trade agreement (FTA) that “approximates very closely those the EU has agreed with Canada or Japan”.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics